Riesco Martínez, M. C., Lamas Paz, A., Rodríguez Gil, Y., Soldevilla Navarro, B., & García Carbonero, R. (2024). Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913).
Chicago Style CitationRiesco Martínez, María Carmen, Arantza Lamas Paz, Yolanda Rodríguez Gil, Beatriz Soldevilla Navarro, and Rocío García Carbonero. Nivolumab Plus Platinum-doublet Chemotherapy in Treatment-naive Patients With Advanced Grade 3 Neuroendocrine Neoplasms of Gastroenteropancreatic or Unknown Origin: The Multicenter Phase 2 NICE-NEC Trial (GETNE-T1913). 2024.
MLA CitationRiesco Martínez, María Carmen, et al. Nivolumab Plus Platinum-doublet Chemotherapy in Treatment-naive Patients With Advanced Grade 3 Neuroendocrine Neoplasms of Gastroenteropancreatic or Unknown Origin: The Multicenter Phase 2 NICE-NEC Trial (GETNE-T1913). 2024.